FDA Eligibility Changes - Individual Donor Assessment
Last Updated on November 13, 2023
LifeServe Blood Center has made changes to the Donor History Questionnaire (DHQ)/QuickPass to implement Individual Donor Assessment in November 2023.
On Thursday, May 11, the U.S. Food and Drug Administration (FDA) finalized recommendations for assessing blood donor eligibility using a set of individual risk-based questions to reduce the risk of transfusion-transmitted HIV.
Blood centers across the United States now have approximately 6 to 12 months to implement the new, mandated rules. This involves modifying many internal systems, processes and software as well as training for blood center team members. LifeServe Blood Center expects to implement the FDA final guidance before the end of 2023 and will update communications regarding the timeline for implementation as information becomes available.